GET Exports & Imports Shop

GET Exports & Imports Shop, established on January 10, 2012, is a proprietary firm based in Nagercoil, Tamil Nadu, India. The company specializes in the wholesale trade of pharmaceutical and medical goods, operating under the National Industry Classification code for wholesale of pharmaceutical and medical goods. As of the financial year 2024–25, GET Exports & Imports Shop is classified as a micro enterprise. The firm's registered office is located at 19/53, Puthoor Road, Eathamozhy Post, District, Nagercoil, India. While specific revenue figures are not publicly disclosed, the company's export activities indicate a significant presence in the pharmaceutical export sector.

GET Exports & Imports Shop operates as a trading entity and does not own manufacturing facilities. The company sources its pharmaceutical products from various manufacturers, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. These products are then exported to international markets, primarily in the Indian Ocean region.

Specific details regarding the CEO, CFO, and other key executives of GET Exports & Imports Shop are not publicly available. The company operates as a proprietary firm, suggesting that ownership and management are likely centralized under a single proprietor. For direct inquiries, the registered office address is 19/53, Puthoor Road, Eathamozhy Post, District, Nagercoil, India.

GET Exports & Imports Shop has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports pharmaceutical products to these regions, indicating compliance with their respective regulatory standards. For instance, the export of "Mirtazapin Heumann 30mg Filmtabletten" to Hamburg, United States, on November 22, 2016, suggests adherence to U.S. FDA regulations. Similarly, exports to European ports like Hamburg indicate compliance with EU regulations. While specific regulatory approvals are not detailed, the company's consistent export activities imply a commitment to meeting international pharmaceutical standards.

GET Exports & Imports Shop has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company exports pharmaceutical products to countries such as Guinea, as evidenced by shipments of "Mirtazapin Heumann 30mg Filmtabletten" to Conakry, Guinea, on November 22, 2016. Additionally, the company's export activities to the Maldives, Seychelles, and Sri Lanka demonstrate its penetration into Southeast Asian markets. While specific WHO prequalification status is not available, the company's engagement in these regions suggests efforts to meet international quality standards.

GET Exports & Imports Shop exhibits a strategic focus on the Indian Ocean region, with significant export activities to the Maldives, Seychelles, and Sri Lanka. This regional concentration allows the company to leverage proximity and established trade routes. However, the lack of diversification into other global markets may expose the company to regional economic fluctuations and geopolitical risks. To mitigate concentration risk, exploring partnerships and expanding into additional markets could be beneficial.

Specific details regarding GET Exports & Imports Shop's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export activities to the United States, such as the shipment of "Mirtazapin Heumann 30mg Filmtabletten" to Hamburg on November 22, 2016, suggest compliance with FDA regulations. However, without explicit FDA approvals or certifications, the company's standing with the FDA remains unverified.

GET Exports & Imports Shop's compliance with World Health Organization (WHO) Good Manufacturing Practice (GMP) and European Union (EU) GMP standards is not explicitly documented. The company's export of pharmaceutical products to European ports, such as Hamburg, indicates potential adherence to EU GMP standards. However, without official certifications or WHO prequalification status, the company's compliance with these international quality standards cannot be conclusively confirmed.

As a trading entity based in India, GET Exports & Imports Shop is subject to regulations set by the Central Drugs Standard Control Organisation (CDSCO) and state drug controllers. The company's export activities suggest compliance with Indian export regulations, including obtaining necessary No Objection Certificates (NOCs) for exporting pharmaceutical products. However, specific details regarding CDSCO manufacturing licenses and state drug controller approvals are not publicly available.

There are no publicly available records of Form 483 observations, warning letters, or import alerts issued to GET Exports & Imports Shop. The company's consistent export activities and absence of reported regulatory actions suggest a stable compliance history. However, the lack of detailed regulatory records limits the ability to fully assess the company's compliance track record.

In the pharmaceutical export sector, GET Exports & Imports Shop faces competition from both large multinational corporations and other regional exporters. While specific competitors are not identified, the company's focus on finished pharmaceutical formulations and its export activities to markets like the Maldives, Seychelles, and Sri Lanka position it within a competitive landscape that includes other exporters targeting these regions. The company's market share in these regions is not publicly disclosed, making direct comparisons challenging.

GET Exports & Imports Shop's key differentiators include its specialization in finished pharmaceutical formulations and its established presence in the Indian Ocean region. The company's focus on products like "Mirtazapin Heumann 30mg Filmtabletten" and "Zincoderm G Cream" indicates a targeted product portfolio. Additionally, the company's consistent export activities to countries such as the Maldives, Seychelles, and Sri Lanka demonstrate its ability to navigate regional trade dynamics effectively.

GET Exports & Imports Shop's current strategic direction appears to be focused on trading finished pharmaceutical formulations, with a particular emphasis on markets in the Indian Ocean region. The company's export activities suggest a strategy centered on leveraging regional trade routes and established market relationships. Looking ahead, expanding into additional markets and diversifying the product portfolio could enhance the company's strategic position and reduce exposure to regional risks.

GET Exports & Imports Shop's track record in exporting pharmaceutical products is notable, with over 17,000 export shipments recorded. The company's consistent export volume and focus on finished pharmaceutical formulations indicate reliability in sourcing and delivering products. However, the lack of publicly available information regarding supplier relationships and manufacturing sources limits a comprehensive assessment of the company's supply chain reliability.

Importers should verify the following certifications when considering GET Exports & Imports Shop as a trading partner:

• FDA Registration: Confirm that the company's products are registered with the U.S. Food and Drug Administration (FDA). Verification can be done through the FDA's official website or by contacting the company directly.

• WHO-GMP Certification: Ensure that the company's manufacturing facilities comply with World Health Organization Good Manufacturing Practice standards. This can be verified by requesting certification documents from the company or checking the WHO's official listings.

• EU GMP Certification: Verify that the company's products meet European Union Good Manufacturing Practice standards. Certification details can be obtained from the company or through the European Medicines Agency (EMA).

• ISO Certification: Check for International Organization for Standardization (ISO) certifications related to quality management systems. These can be verified by requesting certification details from the company or through the International Organization for Standardization's official website.

When conducting due diligence on GET Exports & Imports Shop, consider the following steps:

• Verify Regulatory Compliance: Confirm that the company's products are registered with relevant regulatory bodies such as the FDA, WHO, and EU authorities.

• Assess Product Quality: Request samples and review quality control documentation to ensure products meet required standards.

• Evaluate Financial Stability: Review financial statements and credit reports to assess the company's financial health.

• Inspect Supply Chain Practices: Understand the company's sourcing and manufacturing processes to ensure ethical and reliable supply chain practices.

• Check References and Reviews: Seek feedback from other clients and partners to gauge the company's reputation and reliability.

By following this checklist, importers can make informed